Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China flag China · Delayed Price · Currency is CNY
18.61
-0.05 (-0.27%)
Aug 31, 2026, 3:00 PM CST

SHA:600079 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
23,91523,91825,38624,44522,27620,510
Other Revenue
43.7643.7649.3679.8461.6738.69
23,95923,96225,43524,52522,33820,549
Revenue Growth
-2.76%-5.79%3.71%9.79%8.71%-0.63%
Cost of Revenue
12,19512,43514,12313,30212,63211,777
Gross Profit
11,76311,52711,31211,2239,7068,772
Selling, General & Admin
6,2736,1956,5636,1685,8275,327
Research & Development
1,3971,5011,4711,462966.86810.47
Other Operating Expenses
209.37212.6140.36202.61205.86224.56
Operating Expenses
7,9287,9568,2997,9047,0576,411
Operating Income
3,8363,5713,0143,3192,6492,361
Interest Expense
-271.04-271.04-351.37-354.14-476.57-602.15
Interest & Investment Income
120.19127.63185.18265.56978.8365.38
Currency Exchange Gain (Loss)
-30.92-30.92-23.245.96123.67-58.34
Other Non Operating Income (Expenses)
-107.79-52.11-186.88-130.81120.33-59.2
EBT Excluding Unusual Items
3,5463,3452,6373,1463,3952,007
Impairment of Goodwill
-332.06-332.06-206.98-26.15-35.33-42.68
Gain (Loss) on Sale of Investments
12.1111.8250.08136.8543.427.89
Gain (Loss) on Sale of Assets
55.6252.75-16.29-4.14-51.5126.06
Asset Writedown
-59.77-62.44-104.2-24.72-36.4-7.17
Other Unusual Items
41.4341.4362.91156.13110.86182.16
Pretax Income
3,2643,0562,4233,3843,4262,173
Income Tax Expense
576.77564644.49568.56354.75354.78
Earnings From Continuing Operations
2,6872,4921,7782,8153,0711,818
Minority Interest in Earnings
-656.62-637.12-448.6-680.78-587.19-501.05
Net Income
2,0301,8551,3302,1342,4841,317
Net Income to Common
2,0301,8551,3302,1342,4841,317
Net Income Growth
47.83%39.53%-37.70%-14.07%88.60%30.96%
Shares Outstanding (Basic)
1,6351,6271,6221,6171,6131,587
Shares Outstanding (Diluted)
1,6351,6271,6221,6291,6131,606
Shares Change
1.07%0.36%-0.47%1.01%0.42%16.59%
EPS (Basic)
1.241.140.821.321.540.83
EPS (Diluted)
1.241.140.821.311.540.82
EPS Growth
46.27%39.02%-37.41%-14.94%87.81%12.33%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
2,0481,7861,1438.93-672.27475.78
Free Cash Flow Per Share
1.251.100.700.01-0.420.30
Dividend Per Share
0.4800.4800.4700.4600.1600.150
Dividend Growth
50.00%2.13%2.17%187.50%6.67%50.00%
Gross Margin
49.10%48.11%44.47%45.76%43.45%42.69%
Operating Margin
16.01%14.90%11.85%13.53%11.86%11.49%
Profit Margin
8.47%7.74%5.23%8.70%11.12%6.41%
Free Cash Flow Margin
8.55%7.45%4.50%0.04%-3.01%2.31%
EBITDA
4,8174,5544,0154,1083,3723,020
EBITDA Margin
20.11%19.00%15.79%16.75%15.10%14.70%
D&A For EBITDA
981.08982.641,002788.75723.08659.23
EBIT
3,8363,5713,0143,3192,6492,361
EBIT Margin
16.01%14.90%11.85%13.53%11.86%11.49%
Effective Tax Rate
17.67%18.45%26.60%16.80%10.35%16.33%
Revenue as Reported
23,96223,96225,43524,52522,33820,549